Bamforth Mark R 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Oct 24, 2017
Insider Transaction Report
Form 4
Bamforth Mark R
Director
Transactions
- Award
Stock Option (right to buy)
2017-10-17+75,000→ 75,000 totalExercise: $3.88From: 2017-11-17Exp: 2027-10-17→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning November 17, 2017 and each month thereafter until fully-vested.